nodes	percent_of_prediction	percent_of_DWPC	metapath
Potassium Canrenoate—Intoxication—Saquinavir—acquired immunodeficiency syndrome	0.0322	0.0322	CcSEcCtD
Potassium Canrenoate—Poisoning—Saquinavir—acquired immunodeficiency syndrome	0.0322	0.0322	CcSEcCtD
Potassium Canrenoate—Loose stools—Amprenavir—acquired immunodeficiency syndrome	0.0304	0.0304	CcSEcCtD
Potassium Canrenoate—Loose stools—Efavirenz—acquired immunodeficiency syndrome	0.0184	0.0184	CcSEcCtD
Potassium Canrenoate—Pregnancy—Efavirenz—acquired immunodeficiency syndrome	0.0179	0.0179	CcSEcCtD
Potassium Canrenoate—Loose stools—Saquinavir—acquired immunodeficiency syndrome	0.0156	0.0156	CcSEcCtD
Potassium Canrenoate—Ulcer—Nevirapine—acquired immunodeficiency syndrome	0.0146	0.0146	CcSEcCtD
Potassium Canrenoate—Pregnancy—Lamivudine—acquired immunodeficiency syndrome	0.0146	0.0146	CcSEcCtD
Potassium Canrenoate—Apathy—Efavirenz—acquired immunodeficiency syndrome	0.0142	0.0142	CcSEcCtD
Potassium Canrenoate—Flat affect—Efavirenz—acquired immunodeficiency syndrome	0.0141	0.0141	CcSEcCtD
Potassium Canrenoate—Ileus—Ritonavir—acquired immunodeficiency syndrome	0.0127	0.0127	CcSEcCtD
Potassium Canrenoate—Ulcer—Efavirenz—acquired immunodeficiency syndrome	0.0108	0.0108	CcSEcCtD
Potassium Canrenoate—Ulcer—Delavirdine—acquired immunodeficiency syndrome	0.0103	0.0103	CcSEcCtD
Potassium Canrenoate—Abdominal discomfort—Amprenavir—acquired immunodeficiency syndrome	0.0101	0.0101	CcSEcCtD
Potassium Canrenoate—Phlebitis—Zidovudine—acquired immunodeficiency syndrome	0.00975	0.00976	CcSEcCtD
Potassium Canrenoate—Hyperkalaemia—Delavirdine—acquired immunodeficiency syndrome	0.00956	0.00956	CcSEcCtD
Potassium Canrenoate—Dysarthria—Saquinavir—acquired immunodeficiency syndrome	0.00916	0.00916	CcSEcCtD
Potassium Canrenoate—Ulcer—Saquinavir—acquired immunodeficiency syndrome	0.00916	0.00916	CcSEcCtD
Potassium Canrenoate—Hyperkalaemia—Saquinavir—acquired immunodeficiency syndrome	0.00851	0.00851	CcSEcCtD
Potassium Canrenoate—Abdominal discomfort—Abacavir—acquired immunodeficiency syndrome	0.00789	0.00789	CcSEcCtD
Potassium Canrenoate—Phlebitis—Ritonavir—acquired immunodeficiency syndrome	0.00758	0.00758	CcSEcCtD
Potassium Canrenoate—Flatulence—Amprenavir—acquired immunodeficiency syndrome	0.00725	0.00725	CcSEcCtD
Potassium Canrenoate—Phlebitis—Lamivudine—acquired immunodeficiency syndrome	0.00696	0.00696	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Nelfinavir—acquired immunodeficiency syndrome	0.00674	0.00674	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Nelfinavir—acquired immunodeficiency syndrome	0.00671	0.00671	CcSEcCtD
Potassium Canrenoate—Flatulence—Didanosine—acquired immunodeficiency syndrome	0.00661	0.00661	CcSEcCtD
Potassium Canrenoate—Discomfort—Amprenavir—acquired immunodeficiency syndrome	0.00619	0.00619	CcSEcCtD
Potassium Canrenoate—Flatulence—Nelfinavir—acquired immunodeficiency syndrome	0.00575	0.00576	CcSEcCtD
Potassium Canrenoate—Flatulence—Stavudine—acquired immunodeficiency syndrome	0.00574	0.00574	CcSEcCtD
Potassium Canrenoate—Discomfort—Didanosine—acquired immunodeficiency syndrome	0.00564	0.00564	CcSEcCtD
Potassium Canrenoate—Infection—Didanosine—acquired immunodeficiency syndrome	0.00544	0.00544	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Indinavir—acquired immunodeficiency syndrome	0.00543	0.00543	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Indinavir—acquired immunodeficiency syndrome	0.00541	0.00541	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Amprenavir—acquired immunodeficiency syndrome	0.00539	0.00539	CcSEcCtD
Potassium Canrenoate—Abdominal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00521	0.00521	CcSEcCtD
Potassium Canrenoate—Discomfort—Nevirapine—acquired immunodeficiency syndrome	0.00507	0.00507	CcSEcCtD
Potassium Canrenoate—Flatulence—Zidovudine—acquired immunodeficiency syndrome	0.00499	0.00499	CcSEcCtD
Potassium Canrenoate—Abdominal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00497	0.00497	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Didanosine—acquired immunodeficiency syndrome	0.00491	0.00492	CcSEcCtD
Potassium Canrenoate—Discomfort—Nelfinavir—acquired immunodeficiency syndrome	0.00491	0.00491	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Amprenavir—acquired immunodeficiency syndrome	0.00491	0.00491	CcSEcCtD
Potassium Canrenoate—Discomfort—Abacavir—acquired immunodeficiency syndrome	0.00482	0.00483	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Amprenavir—acquired immunodeficiency syndrome	0.00475	0.00475	CcSEcCtD
Potassium Canrenoate—Pain—Didanosine—acquired immunodeficiency syndrome	0.00468	0.00468	CcSEcCtD
Potassium Canrenoate—Infection—Abacavir—acquired immunodeficiency syndrome	0.00465	0.00465	CcSEcCtD
Potassium Canrenoate—Flatulence—Indinavir—acquired immunodeficiency syndrome	0.00464	0.00464	CcSEcCtD
Potassium Canrenoate—Arrhythmia—Efavirenz—acquired immunodeficiency syndrome	0.00456	0.00456	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Ritonavir—acquired immunodeficiency syndrome	0.00454	0.00454	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Ritonavir—acquired immunodeficiency syndrome	0.00452	0.00452	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Didanosine—acquired immunodeficiency syndrome	0.00448	0.00448	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Nevirapine—acquired immunodeficiency syndrome	0.00442	0.00442	CcSEcCtD
Potassium Canrenoate—Flatulence—Efavirenz—acquired immunodeficiency syndrome	0.00438	0.00438	CcSEcCtD
Potassium Canrenoate—Hypotension—Abacavir—acquired immunodeficiency syndrome	0.00437	0.00437	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Saquinavir—acquired immunodeficiency syndrome	0.00437	0.00437	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Saquinavir—acquired immunodeficiency syndrome	0.00435	0.00435	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Didanosine—acquired immunodeficiency syndrome	0.00433	0.00433	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Didanosine—acquired immunodeficiency syndrome	0.00433	0.00433	CcSEcCtD
Potassium Canrenoate—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.00431	0.00431	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Nelfinavir—acquired immunodeficiency syndrome	0.00428	0.00428	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Stavudine—acquired immunodeficiency syndrome	0.00427	0.00427	CcSEcCtD
Potassium Canrenoate—Discomfort—Zidovudine—acquired immunodeficiency syndrome	0.00426	0.00426	CcSEcCtD
Potassium Canrenoate—Pain—Nevirapine—acquired immunodeficiency syndrome	0.00421	0.00421	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Abacavir—acquired immunodeficiency syndrome	0.0042	0.0042	CcSEcCtD
Potassium Canrenoate—Flatulence—Delavirdine—acquired immunodeficiency syndrome	0.00419	0.00419	CcSEcCtD
Potassium Canrenoate—Confusional state—Zidovudine—acquired immunodeficiency syndrome	0.00416	0.00417	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.00411	0.00411	CcSEcCtD
Potassium Canrenoate—Pain—Nelfinavir—acquired immunodeficiency syndrome	0.00408	0.00408	CcSEcCtD
Potassium Canrenoate—Pain—Stavudine—acquired immunodeficiency syndrome	0.00406	0.00406	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Nevirapine—acquired immunodeficiency syndrome	0.00406	0.00406	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.00402	0.00403	CcSEcCtD
Potassium Canrenoate—Pain—Abacavir—acquired immunodeficiency syndrome	0.004	0.004	CcSEcCtD
Potassium Canrenoate—Discomfort—Indinavir—acquired immunodeficiency syndrome	0.00396	0.00396	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.00393	0.00393	CcSEcCtD
Potassium Canrenoate—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.00393	0.00393	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.0039	0.0039	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.00389	0.00389	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.00389	0.00389	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.00389	0.00389	CcSEcCtD
Potassium Canrenoate—Flatulence—Ritonavir—acquired immunodeficiency syndrome	0.00388	0.00388	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.00386	0.00386	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.00383	0.00383	CcSEcCtD
Potassium Canrenoate—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00382	0.00382	CcSEcCtD
Potassium Canrenoate—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00379	0.00379	CcSEcCtD
Potassium Canrenoate—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00378	0.00378	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.00377	0.00377	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.00377	0.00377	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.00376	0.00376	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.00376	0.00376	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.00374	0.00375	CcSEcCtD
Potassium Canrenoate—Discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00374	0.00374	CcSEcCtD
Potassium Canrenoate—Flatulence—Saquinavir—acquired immunodeficiency syndrome	0.00373	0.00373	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.00371	0.00371	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.0037	0.0037	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.0037	0.0037	CcSEcCtD
Potassium Canrenoate—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.00366	0.00366	CcSEcCtD
Potassium Canrenoate—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.00358	0.00358	CcSEcCtD
Potassium Canrenoate—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00357	0.00357	CcSEcCtD
Potassium Canrenoate—Flatulence—Lamivudine—acquired immunodeficiency syndrome	0.00356	0.00356	CcSEcCtD
Potassium Canrenoate—Pain—Zidovudine—acquired immunodeficiency syndrome	0.00353	0.00353	CcSEcCtD
Potassium Canrenoate—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.00353	0.00353	CcSEcCtD
Potassium Canrenoate—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.0035	0.0035	CcSEcCtD
Potassium Canrenoate—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00348	0.00348	CcSEcCtD
Potassium Canrenoate—Rash—Didanosine—acquired immunodeficiency syndrome	0.00345	0.00345	CcSEcCtD
Potassium Canrenoate—Infection—Delavirdine—acquired immunodeficiency syndrome	0.00345	0.00345	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.00345	0.00345	CcSEcCtD
Potassium Canrenoate—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00345	0.00345	CcSEcCtD
Potassium Canrenoate—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.00342	0.00342	CcSEcCtD
Potassium Canrenoate—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.00341	0.00341	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.0034	0.0034	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.00338	0.00338	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00337	0.00337	CcSEcCtD
Potassium Canrenoate—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.00336	0.00336	CcSEcCtD
Potassium Canrenoate—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00331	0.00331	CcSEcCtD
Potassium Canrenoate—Pain—Indinavir—acquired immunodeficiency syndrome	0.00328	0.00329	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.00326	0.00327	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.00326	0.00327	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00326	0.00326	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.00326	0.00326	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00325	0.00325	CcSEcCtD
Potassium Canrenoate—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00325	0.00325	CcSEcCtD
Potassium Canrenoate—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.00324	0.00325	CcSEcCtD
Potassium Canrenoate—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.00324	0.00324	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.0032	0.0032	CcSEcCtD
Potassium Canrenoate—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00319	0.00319	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.00317	0.00317	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.00314	0.00314	CcSEcCtD
Potassium Canrenoate—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00313	0.00313	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.00312	0.00312	CcSEcCtD
Potassium Canrenoate—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.00312	0.00312	CcSEcCtD
Potassium Canrenoate—Pain—Efavirenz—acquired immunodeficiency syndrome	0.0031	0.0031	CcSEcCtD
Potassium Canrenoate—Rash—Nevirapine—acquired immunodeficiency syndrome	0.0031	0.0031	CcSEcCtD
Potassium Canrenoate—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.0031	0.0031	CcSEcCtD
Potassium Canrenoate—Infection—Saquinavir—acquired immunodeficiency syndrome	0.00307	0.00307	CcSEcCtD
Potassium Canrenoate—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00304	0.00304	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.00304	0.00304	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.00304	0.00304	CcSEcCtD
Potassium Canrenoate—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00303	0.00303	CcSEcCtD
Potassium Canrenoate—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00302	0.00302	CcSEcCtD
Potassium Canrenoate—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00301	0.00301	CcSEcCtD
Potassium Canrenoate—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.003	0.003	CcSEcCtD
Potassium Canrenoate—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.003	0.003	CcSEcCtD
Potassium Canrenoate—Rash—Stavudine—acquired immunodeficiency syndrome	0.003	0.003	CcSEcCtD
Potassium Canrenoate—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00299	0.00299	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.00299	0.00299	CcSEcCtD
Potassium Canrenoate—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00298	0.00298	CcSEcCtD
Potassium Canrenoate—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.00297	0.00297	CcSEcCtD
Potassium Canrenoate—Pain—Delavirdine—acquired immunodeficiency syndrome	0.00297	0.00297	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.00297	0.00297	CcSEcCtD
Potassium Canrenoate—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.00296	0.00296	CcSEcCtD
Potassium Canrenoate—Rash—Abacavir—acquired immunodeficiency syndrome	0.00295	0.00295	CcSEcCtD
Potassium Canrenoate—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00295	0.00295	CcSEcCtD
Potassium Canrenoate—Infection—Lamivudine—acquired immunodeficiency syndrome	0.00293	0.00293	CcSEcCtD
Potassium Canrenoate—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00292	0.00292	CcSEcCtD
Potassium Canrenoate—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.00289	0.00289	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.00288	0.00288	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.00287	0.00287	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.00287	0.00287	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.00286	0.00286	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.00284	0.00284	CcSEcCtD
Potassium Canrenoate—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00283	0.00283	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00283	0.00283	CcSEcCtD
Potassium Canrenoate—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00282	0.00282	CcSEcCtD
Potassium Canrenoate—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00278	0.00278	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.00278	0.00278	CcSEcCtD
Potassium Canrenoate—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.00276	0.00276	CcSEcCtD
Potassium Canrenoate—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.00275	0.00276	CcSEcCtD
Potassium Canrenoate—Pain—Ritonavir—acquired immunodeficiency syndrome	0.00275	0.00275	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.00274	0.00275	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.00274	0.00275	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.00265	0.00265	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.00265	0.00265	CcSEcCtD
Potassium Canrenoate—Pain—Saquinavir—acquired immunodeficiency syndrome	0.00264	0.00264	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.00263	0.00263	CcSEcCtD
Potassium Canrenoate—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00263	0.00263	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.00263	0.00263	CcSEcCtD
Potassium Canrenoate—Rash—Zidovudine—acquired immunodeficiency syndrome	0.0026	0.0026	CcSEcCtD
Potassium Canrenoate—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.0026	0.0026	CcSEcCtD
Potassium Canrenoate—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.0026	0.0026	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.00255	0.00255	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.00254	0.00254	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.00254	0.00254	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.00253	0.00253	CcSEcCtD
Potassium Canrenoate—Pain—Lamivudine—acquired immunodeficiency syndrome	0.00252	0.00252	CcSEcCtD
Potassium Canrenoate—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.00249	0.00249	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.00248	0.00248	CcSEcCtD
Potassium Canrenoate—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00245	0.00245	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.00244	0.00244	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.00244	0.00244	CcSEcCtD
Potassium Canrenoate—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00244	0.00244	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.00243	0.00243	CcSEcCtD
Potassium Canrenoate—Rash—Indinavir—acquired immunodeficiency syndrome	0.00242	0.00242	CcSEcCtD
Potassium Canrenoate—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.00242	0.00242	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.00241	0.00241	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.00238	0.00238	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.00233	0.00233	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.00233	0.00233	CcSEcCtD
Potassium Canrenoate—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00231	0.00231	CcSEcCtD
Potassium Canrenoate—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.0023	0.0023	CcSEcCtD
Potassium Canrenoate—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00229	0.00229	CcSEcCtD
Potassium Canrenoate—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.00229	0.00229	CcSEcCtD
Potassium Canrenoate—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00228	0.00228	CcSEcCtD
Potassium Canrenoate—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.00222	0.00222	CcSEcCtD
Potassium Canrenoate—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.00221	0.00221	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.0022	0.0022	CcSEcCtD
Potassium Canrenoate—Rash—Delavirdine—acquired immunodeficiency syndrome	0.00219	0.00219	CcSEcCtD
Potassium Canrenoate—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.00219	0.00219	CcSEcCtD
Potassium Canrenoate—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.00216	0.00216	CcSEcCtD
Potassium Canrenoate—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.00212	0.00212	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.00211	0.00211	CcSEcCtD
Potassium Canrenoate—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00206	0.00206	CcSEcCtD
Potassium Canrenoate—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.00204	0.00204	CcSEcCtD
Potassium Canrenoate—Rash—Ritonavir—acquired immunodeficiency syndrome	0.00202	0.00202	CcSEcCtD
Potassium Canrenoate—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.00202	0.00202	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.00202	0.00202	CcSEcCtD
Potassium Canrenoate—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.00196	0.00197	CcSEcCtD
Potassium Canrenoate—Rash—Saquinavir—acquired immunodeficiency syndrome	0.00195	0.00195	CcSEcCtD
Potassium Canrenoate—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.00195	0.00195	CcSEcCtD
Potassium Canrenoate—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.00191	0.00191	CcSEcCtD
Potassium Canrenoate—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.00187	0.00187	CcSEcCtD
Potassium Canrenoate—Rash—Lamivudine—acquired immunodeficiency syndrome	0.00186	0.00186	CcSEcCtD
Potassium Canrenoate—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.00186	0.00186	CcSEcCtD
Potassium Canrenoate—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.00184	0.00184	CcSEcCtD
Potassium Canrenoate—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.00175	0.00175	CcSEcCtD
Potassium Canrenoate—Prednisone—ALB—acquired immunodeficiency syndrome	8.12e-05	0.403	CrCbGaD
Potassium Canrenoate—Methyltestosterone—ALB—acquired immunodeficiency syndrome	7.6e-05	0.378	CrCbGaD
Potassium Canrenoate—Testosterone—ALB—acquired immunodeficiency syndrome	4.41e-05	0.219	CrCbGaD
